These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 9309149)

  • 1. [Morphological reversion of tumor cells by histone deacetylase inhibitors and radicicol].
    Yoshida M; Honda A; Horinouchi S
    Gan To Kagaku Ryoho; 1997 Sep; 24(11):1512-8. PubMed ID: 9309149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of morphological transformation by radicicol is accompanied by enhanced gelsolin expression.
    Kwon HJ; Yoshida M; Nagaoka R; Obinata T; Beppu T; Horinouchi S
    Oncogene; 1997 Nov; 15(21):2625-31. PubMed ID: 9399650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphology of ras-transformed cells becomes apparently normal again with tyrosine kinase inhibitors without a decrease in the ras-GTP complex.
    Kwon HJ; Yoshida M; Muroya K; Hattori S; Nishida E; Fukui Y; Beppu T; Horinouchi S
    J Biochem; 1995 Jul; 118(1):221-8. PubMed ID: 8537316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potent and specific inhibition of p60v-src protein kinase both in vivo and in vitro by radicicol.
    Kwon HJ; Yoshida M; Fukui Y; Horinouchi S; Beppu T
    Cancer Res; 1992 Dec; 52(24):6926-30. PubMed ID: 1458481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apicidin, a histone deacetylase inhibitor, inhibits proliferation of tumor cells via induction of p21WAF1/Cip1 and gelsolin.
    Han JW; Ahn SH; Park SH; Wang SY; Bae GU; Seo DW; Kwon HK; Hong S; Lee HY; Lee YW; Lee HW
    Cancer Res; 2000 Nov; 60(21):6068-74. PubMed ID: 11085529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radicicol inhibits tyrosine phosphorylation of the mitotic Src substrate Sam68 and retards subsequent exit from mitosis of Src-transformed cells.
    Pillay I; Nakano H; Sharma SV
    Cell Growth Differ; 1996 Nov; 7(11):1487-99. PubMed ID: 8930398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of RAS and MOS transformation by radicicol.
    Zhao JF; Nakano H; Sharma S
    Oncogene; 1995 Jul; 11(1):161-73. PubMed ID: 7624124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitors of anchorage-independent growth affect the growth of transformed cells on poly(2-hydroxyethyl methacrylate)-coated surfaces.
    Fukazawa H; Nakano S; Mizuno S; Uehara Y
    Int J Cancer; 1996 Sep; 67(6):876-82. PubMed ID: 8824562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced cell differentiation when RB is hypophosphorylated and down-regulated by radicicol, a SRC-kinase inhibitor.
    Yen A; Soong S; Kwon HJ; Yoshida M; Beppu T; Varvayanis S
    Exp Cell Res; 1994 Sep; 214(1):163-71. PubMed ID: 7521842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxamflatin is a novel antitumor compound that inhibits mammalian histone deacetylase.
    Kim YB; Lee KH; Sugita K; Yoshida M; Horinouchi S
    Oncogene; 1999 Apr; 18(15):2461-70. PubMed ID: 10229197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting of the protein chaperone, HSP90, by the transformation suppressing agent, radicicol.
    Sharma SV; Agatsuma T; Nakano H
    Oncogene; 1998 May; 16(20):2639-45. PubMed ID: 9632140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trichostatin A induces morphological changes and gelsolin expression by inhibiting histone deacetylase in human carcinoma cell lines.
    Hoshikawa Y; Kwon HJ; Yoshida M; Horinouchi S; Beppu T
    Exp Cell Res; 1994 Sep; 214(1):189-97. PubMed ID: 8082721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FR901228, a potent antitumor antibiotic, is a novel histone deacetylase inhibitor.
    Nakajima H; Kim YB; Terano H; Yoshida M; Horinouchi S
    Exp Cell Res; 1998 May; 241(1):126-33. PubMed ID: 9633520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Halohydrin and oxime derivatives of radicicol: synthesis and antitumor activities.
    Agatsuma T; Ogawa H; Akasaka K; Asai A; Yamashita Y; Mizukami T; Akinaga S; Saitoh Y
    Bioorg Med Chem; 2002 Nov; 10(11):3445-54. PubMed ID: 12213458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PKCepsilon is essential for gelsolin expression by histone deacetylase inhibitor apicidin in human cervix cancer cells.
    Eun DW; Ahn SH; You JS; Park JW; Lee EK; Lee HN; Kang GM; Lee JC; Choi WS; Seo DW; Han JW
    Biochem Biophys Res Commun; 2007 Mar; 354(3):769-75. PubMed ID: 17257588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depudecin induces morphological reversion of transformed fibroblasts via the inhibition of histone deacetylase.
    Kwon HJ; Owa T; Hassig CA; Shimada J; Schreiber SL
    Proc Natl Acad Sci U S A; 1998 Mar; 95(7):3356-61. PubMed ID: 9520369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Protein kinase inhibitors--screening of new molecular target therapeutics].
    Uehara Y
    Gan To Kagaku Ryoho; 1997 Jan; 24(2):136-44. PubMed ID: 9030224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic regulation of gelsolin expression in human breast cancer cells.
    Mielnicki LM; Ying AM; Head KL; Asch HL; Asch BB
    Exp Cell Res; 1999 May; 249(1):161-76. PubMed ID: 10328963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic antineoplastic action of DNA methylation inhibitor 5-AZA-2'-deoxycytidine and histone deacetylase inhibitor depsipeptide on human breast carcinoma cells.
    Primeau M; Gagnon J; Momparler RL
    Int J Cancer; 2003 Jan; 103(2):177-84. PubMed ID: 12455031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KF25706, a novel oxime derivative of radicicol, exhibits in vivo antitumor activity via selective depletion of Hsp90 binding signaling molecules.
    Soga S; Neckers LM; Schulte TW; Shiotsu Y; Akasaka K; Narumi H; Agatsuma T; Ikuina Y; Murakata C; Tamaoki T; Akinaga S
    Cancer Res; 1999 Jun; 59(12):2931-8. PubMed ID: 10383157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.